Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P DOMINGO

Showing results (241-250 of 276) with videos related to

Pageof 28
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 studyH Knobel, J M Miró, P Domingo, et al.
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 19, 2001
[Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society]J A Iribarren, J T Ramos, L Guerra, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2012
Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosisMaria P Domingo, Cristina Colmenarejo, Luis Martínez-Lostao, et al.
HIV Medicine|January 22, 2011
A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophyX Escoté, A Megia, M López-Dupla, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
HIV Clinical Trials|December 4, 2010
Comparison of antiviral activity of regimens containing nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue therapy (The NUCREST Study)J A Pérez-Molina, O Serrano, A Milinkovic, et al.
HIV Medicine|September 18, 2008
Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227K Ruxrungtham, R J Pedro, G H Latiff, et al.
HIV Medicine|October 24, 2012
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studiesM Calvo-Sánchez, R Perelló, I Pérez, et al.
Archives of Internal Medicine|November 5, 1999
Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance GroupN Barquet, P Domingo, J A Caylà, et al.
Pageof 28

Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Journal of Acquired Immune Deficiency Syndromes (1999)|October 2, 2001
Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 studyH Knobel, J M Miró, P Domingo, et al.
HIV Medicine|January 29, 2019
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJ M Llibre, A Montoliu, J M Miró, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 19, 2001
[Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society]J A Iribarren, J T Ramos, L Guerra, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2012
Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosisMaria P Domingo, Cristina Colmenarejo, Luis Martínez-Lostao, et al.
HIV Medicine|January 22, 2011
A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophyX Escoté, A Megia, M López-Dupla, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)S Monge, M Díez, M Alvarez, et al.
HIV Clinical Trials|December 4, 2010
Comparison of antiviral activity of regimens containing nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue therapy (The NUCREST Study)J A Pérez-Molina, O Serrano, A Milinkovic, et al.
HIV Medicine|September 18, 2008
Impact of reverse transcriptase resistance on the efficacy of TMC125 (etravirine) with two nucleoside reverse transcriptase inhibitors in protease inhibitor-naïve, nonnucleoside reverse transcriptase inhibitor-experienced patients: study TMC125-C227K Ruxrungtham, R J Pedro, G H Latiff, et al.
HIV Medicine|October 24, 2012
Differences between HIV-infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case-control studiesM Calvo-Sánchez, R Perelló, I Pérez, et al.
Archives of Internal Medicine|November 5, 1999
Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance GroupN Barquet, P Domingo, J A Caylà, et al.
Pageof 28